Intuitive Surgical, a leading company in minimally invasive robotic-assisted surgery, has announced its preliminary financial and operational results for the fourth quarter and full year 2024, ahead of its scheduled presentation at the 43rd Annual J.P. Morgan Healthcare Conference.
Intuitive Celebrates Robust Performance
In a report, the company celebrated its remarkable performance in the robotic surgical procedure. Worldwide procedures performed with da Vinci surgical systems surged by 18% compared to Q4 2023, contributing to an overall 17% growth in 2024.
On the other hand, preliminary Q4 2024 revenue reached $2.41 billion, a 25% increase from $1.93 billion in Q4 2023. Full-year revenue rose by 17% to $8.35 billion.
The company has also witnessed growth in the system placements surge. It placed 493 da Vinci surgical systems in Q4 2024, a 19% increase from 415 systems in Q4 2023. This includes 174 da Vinci 5 systems.
While the automation and artificial intelligence (AI) industry is on the rise, Intuitive received strong demand for instruments and accessories. Q4 2024 revenue from instruments and accessories climbed 23% to $1.41 billion. This is mainly driven by higher da Vinci and Ion procedure volumes.
In the forecast, the company expects worldwide da Vinci procedures to increase by 13% to 16% in 2025.
Intuitive CEO Gary Guthart praised the company’s growth, saying “We are pleased with customer adoption of da Vinci 5, Ion, and SP during the quarter and full year. We remain focused on delivering the goals we share with our customers, centered on improving patient outcomes.”
Latest Stories:
Netradyne Raises $90M In Funding to Advance AI-powered Fleet Safety
Google Automotive AI Agent Integrates with Mercedes-Benz
Singtel Launches AI-Themed CNY Film Showcasing Smart Home Innovation
What is your reaction?
